Heron Therapeutics Inc HRTX:NASDAQ (Common Stock)

LastChange / % ChangeDividend YieldVolumeAvg Volume (10 day)
7.52 0.03   0.40% 141,221139.6K
Market data is delayed by at least 20 minutes.
Summary chart showing the current equity's performance of over the past 1 days
  • Advanced Charts
  • Embed the above chart in your blog or website

    Customize, copy, and then paste the generated code into your website.

Previous close 10/8/2014

Latest News Headlines for Heron Therapeutics Inc

No News for Heron Therapeutics Inc

Latest Annual and Quarterly SEC Filings

More Filings
10-K

This report contains detailed information about the company's business finances and management.

10-Q

Quarterly reports contain financial statement, a discussion from management and a list of company events (stock splits, acquisitions, etc.)

Company Background

Heron Therapeutics Inc, formerly A.P. Pharma, Inc. is a specialty pharmaceutical company developing pharmaceutical products using its Biochronomer polymer-based drug delivery platform. The Company's lead product candidate, APF530, is being developed for the prevention of acute chemotherapy-induced nausea and vomiting (CINV) for patients undergoing both moderately and highly emetogenic chemotherapy and for the prevention of delayed CINV for patients undergoing moderately emetogenic chemotherapy. APF530 contains the 5-HT3 antagonist granisetron formulated in the Company's Biochronomer drug delivery system, which allows therapeutic drug levels to be maintained for five days with a single subcutaneous injection.

http://www.appharma.com

Loading...

collapse, right-facing arrow indicating collapsed view of sectionOverview

A table providing an overview of the stock
Bid | Size-- | --
Ask | Size-- | --
Price Open7.48
Previous Close7.52
Day High--
Day Low--
52 Week High3/20/2014 | 15.8188
52 Week Low10/9/2013 | 6.70
% Off 52 Week High-52.46%
% Off 52 Week Low12.24%
Beta (5 Yr)0.48
Volatility Avg10/8/2014 | 56.12
10-Day Avg. Volume139,554
Market data is delayed by at least 20 minutes.

collapse, right-facing arrow indicating collapsed view of sectionFundamentals

A table providing the fundamentals of the stock
EPS (TTM)6/30/2014 | -3.11
P/E Ratio6/30/2014 | --
Market CapMicro Cap | 217M
Shares Outstanding28.91M
Float28.7M

collapse, right-facing arrow indicating collapsed view of sectionDividends

A table providing information about the dividends of the stock
Dividend Yield--
Ex-Date--
Dividend Announcement--
Date of Record--
Payable-- - --
Payable Date--

collapse, right-facing arrow indicating collapsed view of sectionShare Statistics

A table providing statistics about shares of the stock
Shares Short1.19M
Short Ratio12.3
Short % of Float4.16%
As of 9/15/2014

Peers Information HelpHRTX Heron Therapeutics Inc vs. Peers

Peers 
HRTX
Heron Therapeutics Inc
-15.51%
Pacira Pharmaceuticals Inc
76.26%
DURECT Corporation
-23.12%
HRTX
Heron Therapeutics Inc
0.00%
Pacira Pharmaceuticals Inc
--
DURECT Corporation
--
HRTX
Heron Therapeutics Inc
0.40%
Pacira Pharmaceuticals Inc
3.87%
DURECT Corporation
0.00%
Compare these stocks